In conclusion, our study revealed the synergistic mechanism of GLB and cisplatin and demonstrated that the ROS-mediated JNK pathway was a crucial mediator for the antitumor action of GLB in combination with cisplatin in ovarian cancer cells. This evidence concerns the gene MAPK8 and ovarian carcinoma.